US Nurse Contracts Ebola

Despite wearing protective gear, a nurse at Texas Health Presbyterian Hospital in Dallas who helped treat the first US Ebola patient has tested positive for the virus.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Transmission electron micrograph of the Ebola virusWIKIMEDIA, CDC, FREDERICK MURPHYThis past weekend marked the first time a patient in the U.S. has contracted the Ebola virus, which continues its rampage through West Africa. The US Centers for Disease Control and Prevention (CDC) confirmed the diagnosis on Sunday (October 12). The patient, a nurse at Texas Health Presbyterian Hospital in Dallas, is now reported to be in stable condition, Texas Health Resources chief clinical officer Dan Varga told CNN, and another person, a “close contact” of the nurse, has been placed in isolation.

The nurse, identified by the Houston Chronicle (Chron) as Nina Pham, is believed to have caught the virus during her multiple visits with Thomas Eric Duncan, the first US patient with Ebola who died last week. According to the Chron, Phame was one of about 70 health-care workers who helped treat Duncan, drawing his blood, intubating him, and cleaning up his bodily fluids. Pham apparently had “extensive contact” on “multiple occasions” with Duncan, CDC Director Tom Frieden said at a news conference Sunday. And despite having worn a protective gown, gloves, mask, and a shield, “at some point, there was a breach in protocol, and that breach in protocol resulted in this infection.”

The Dallas Fire Department has decontaminated Pham’s car and the public areas ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies